Cancer cells

Supporting Rare Disease Innovation with Compliant, High-Quality Sample Sourcing

   

Rare oncology indications from solid tumours to malignant haematological diseases represent one of the most pressing unmet medical needs worldwide. With over 7,000 rare diseases identified globally and nearly 45% of recent European drug approvals classified as orphan medicines, innovation in rare disease research is accelerating at pace.

Advances in genomics, next-generation sequencing (NGS), and precision medicine are transforming oncology. Biomarker-driven trials, molecular stratification strategies, and translational research programmes all depend on one critical factor: access to high-quality, ethically sourced human biological samples. When patient populations are limited, every sample matters.

At Tebubio, we help researchers secure the biological materials they need reliably, compliantly, and without operational friction, so you can focus on discovery.

 

Human Sample Sourcing, Simplified and De‑Risked by Tebubio

Sourcing human biological samples should not slow down your science. Tebubio de-risks and streamlines your procurement process at every step:

 

Global Biobank Network
We collaborate with a trusted international network of biobanks and clinical partners that meet strict ethical and quality standards, expanding your access to rare and well-characterised cohorts.
EU-Compliant Sourcing
We manage all relevant European compliance and documentation, ensuring that samples are ethically approved for research use and handled according to the highest regulatory standards.
Fully Authorised Import & Export
Every cross-border transfer complies with French Ministry of Research procedures and EU-level expectations. No customs uncertainty. No regulatory surprises.
Full Product Traceability
From temperature-controlled logistics to customs handling, we ensure seamless delivery to your laboratory with documented traceability.
Reduced Sourcing Variability
Our curated supplier selection ensures consistent quality standards across batches, reducing variability that may compromise reproducibility.
One Expert Point of Contact
We centralise communication, coordination, and after-sales support through a dedicated specialist.
Proactive Risk Anticipation
We identify and resolve ethical, regulatory, and operational challenges before they impact your timelines.

What Do We Offer?

Our approach is built around your study design, timelines, and scientific objectives.

Biobank Selection
If you face a short project timeline or immediate need, we rapidly identify suitable biobanks within our global network to broaden your access to rare samples.
Prospective Collection
Defined inclusion and exclusion criteria? We conduct a qualification discussion to understand your project scope and organise prospective collections tailored to your research protocol.
Patient Conditions
Access to both healthy donors and oncology patients, including rare and complex disease profiles.
Matched Samples
Need paired materials for comparative analyses or longitudinal research? We source matched samples aligned with your study requirements.
Mutation Status
Some partner biobanks provide known mutation status. Alternatively, we coordinate NGS testing alongside sample procurement.

Sample Types Available

We provide access to a comprehensive range of oncology-relevant materials:

  • FFPE tissue

  • Fresh Frozen (FF) tissue

  • Fresh tissue

  • NAT (Normal Adjacent to Tumour)

  • PBMCs

  • Bulk PBMCs (LeukoLots™)

  • Leukopak

  • Plasma

  • Serum

  • Buffy coat

  • Bone marrow aspirates

  • Bone marrow trephine biopsy (FFPE or FF)

  • BMMC (bone marrow mononuclear cells)

  • Dissociated tumour cells

If you require a specific processing method, preservation protocol, or clinical annotation dataset, we will assess feasibility with our partners.

Supporting Your Research Every Step of the Way

Why Work With Tebubio?

 

  • Ethically Compliant
  • Extensive Networks
  • Quality
  • Save Time
  • Flexibility
  • Reliability
  • Simplicity

Designed Around Your Research Needs

 

Whether you are:

  • Validating a novel biomarker

  • Stratifying patient cohorts

  • Designing a biomarker-driven clinical study

  • Complementing your existing biobank

  • Launching a translational research programme

Tebubio ensures your access to compliant, high-quality samples does not become a bottleneck.

Let’s Discuss Your Project

 

 

Whether you have an urgent requirement or are preparing your next rare oncology study, Inês Santarino, PhD, your Product Manager at Tebubio, is available for a qualification call to assess your needs.

 

Accelerate Your Rare Oncology Research Together. Let’s Talk.

Talk to our experts to discuss your project, explore suitable samples, and get personalised support, all in compliance with the highest ethical and regulatory standards.